Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 58 min ago
Peer-reviewedCC BYJournal of clinical medicine

Contemporary Clinical Spectrum and Factors Associated with Mortality in Infective Endocarditis: A Multicenter Cohort Study (COSMO-IE)

25 more authors
29 affiliations
  1. 1Department of Cardiology, Faculty of Medicine, Dokuz Eylul University, Izmir 35340, Türkiye
  2. 2Department of Cardiology, University of Bakırçay, Izmir 35665, Türkiye
  3. 3Department of Cardiology, Başakşehir Çam and Sakura City Hospital, Istanbul 34480, Türkiye
  4. 4Department of Cardiology, Şehit Prof. Dr. İlhan Varank Sancaktepe Training and Research Hospital, Istanbul 34785, Türkiye
  5. 5Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Istanbul 34147, Türkiye
  6. 6Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Kocaeli University, Kocaeli 41380, Türkiye
  7. 7Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Dr. Suat Seren Chest Diseases and Surgery Training and Research Hospital, Izmir 35110, Türkiye
  8. 8Department of Infectious Diseases and Clinical Microbiology, Kayseri City Hospital, Kayseri 38080, Türkiye
  9. 9Department of Cardiology, Kartal Koşuyolu Training and Research Hospital, Istanbul 34865, Türkiye
  10. 10Department of Cardiology, Izmir Katip Çelebi University Atatürk Training and Research Hospital, Izmir 35360, Türkiye
  11. 11Department of Cardiology, Ankara Training and Research Hospital, Ankara 06230, Türkiye
  12. 12Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Antalya Training and Research Hospital, Antalya 07100, Türkiye
  13. 13Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Istanbul Kartal Dr. Lütfi Kırdar City Hospital, Istanbul 34865, Türkiye
  14. 14Department of Cardiology, Tepecik Training and Research Hospital, Izmir 35020, Türkiye
  15. 15Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, İnönü University, Malatya 44280, Türkiye
  16. 16Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Atatürk University, Erzurum 25240, Türkiye
  17. 17Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Sakarya University, Sakarya 54187, Türkiye
  18. 18Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Gazi Yaşargil Training and Research Hospital, Diyarbakır 21070, Türkiye
  19. 19Department of Infectious Diseases and Clinical Microbiology, Istanbul Medipol University, Istanbul 34214, Türkiye
  20. 20Department of Cardiology, University of Health Sciences, Gazi Yaşargil Training and Research Hospital, Diyarbakır 21070, Türkiye
  21. 21Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Recep Tayyip Erdoğan University, Rize 53100, Türkiye
  22. 22Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Sivas Cumhuriyet University, Sivas 58140, Türkiye
  23. 23Department of Cardiology, Batman Training and Research Hospital, Batman 72070, Türkiye
  24. 24Department of Infectious Diseases and Clinical Microbiology, Necmettin Erbakan University, Konya 42090, Türkiye
  25. 25Department of Cardiology, Van Training and Research Hospital, Van 65170, Türkiye
  26. 26Department of Cardiology, Faculty of Medicine, Hitit University, Çorum 19040, Türkiye
  27. 27Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Harran University, Şanlıurfa 63300, Türkiye
  28. 28Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Tekirdağ Namık Kemal University, Tekirdağ 59030, Türkiye
  29. 29Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Dokuz Eylul University, Izmir 35340, Türkiye

Abstract

Background: Despite continuous advancements in diagnostic imaging and targeted antimicrobial protocols for infective endocarditis (IE), global epidemiological data show that both disease burden and incidence continue to rise. This study aimed to evaluate real-world diagnostic and treatment approaches in accordance with the 2023 European Society of Cardiology (ESC) IE Guidelines and to identify independent predictors of mortality in a contemporary patient cohort. Methods: This multicenter, retrospective cohort study analyzed data from 470 consecutive adult patients diagnosed with IE across 27 academic reference centers between 1 September 2023 and 1 June 2025. Patients were managed and adjudicated according to the 2023 ESC diagnostic criteria. Demographic data, clinical characteristics, microbiological profiles, imaging findings, empirical antibiotic therapy patterns, and clinical outcomes were analyzed. Independent predictors of mortality were determined using multivariable Cox proportional hazards regression models. Results: The mean age of the overall study population was 58.08 ± 16.81 years, with a male predominance (60.6%, n = 285). Staphylococcus aureus was the most frequently isolated pathogen (27.9%), with a high proportion of methicillin resistance (38.9%). Hospital-acquired IE was identified in 41.1% of cases. Surgical treatment was performed in 40.6% (n = 191) of the cohort. The 28-day mortality rate was 11.9%, and the overall mortality during follow-up reached 26.4%. Multivariable Cox regression analysis identified hospital-acquired IE (HR = 2.247; 95% CI: 1.216–4.167; p = 0.010) and the presence of major clinical complications (HR = 4.207; 95% CI: 1.556–11.378; p = 0.005) as the strongest independent predictors of mortality. Conclusions: Contemporary infective endocarditis is a highly complex and fatal disease characterized by a prominent healthcare-associated burden and a predominant staphylococcal etiology. The occurrence of major clinical complications and hospital-acquired infections were the primary independent predictors of mortality.

Related

  1. Integrated Clinical, Biological, and Echocardiographic Factors Independently Associated With In-Hospital Mortality in Infective Endocarditis: A Single-Centre Cohort Study From Morocco
    Tariq El Karimy, Hiba Rizkou, Joumana Elmasrioui +1
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Incremental Predictive Value of Post-Baseline Surgery and the Impact of Temporal Coding on Mortality Associations in Infective Endocarditis: A Temporally Validated Cohort Study
    Banu Karaca, Aykan Çelik, Mert İnan +2
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. External Validation of the PACTO Risk Score for Infective Endocarditis in Patients With Coagulase-Negative Staphylococcal Bacteremia: A Multicenter Cohort Study.
    Antonio Ramos-Martínez, Itziar Diego-Yagüe, Luis Eduardo López-Cortés +10
    Open forum infectious diseasesPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
  4. Admission to a referral centre and one-year mortality among patients with infective endocarditis in a French multicentre cohort
    Benjamin Lefèvre, Marie-Line Erpelding, Yoann Dominique +9
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral biologyCardiovascular medicineHAL
  5. Hepatic Mycotic Aneurysms in TAVI-Associated Infective Endocarditis Caused by Streptococcus gallolyticus: A Case Report.
    Mihai Grigore, Camelia Nicolae, Horațiu Moldovan +2
    Reports (MDPI)Peer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
BibTeX
@article{kıs2026contemporary,
  title = {{Contemporary Clinical Spectrum and Factors Associated with Mortality in Infective Endocarditis: A Multicenter Cohort Study (COSMO-IE)}},
  author = {Mehmet Kış and Oktay Şenöz and Duygu İnan and Onur Akhan and Esra Canbolat Ünlü and Özlem Güler and Tuba Tatlı Kış and Şemsi Nur Karabela and Duygu Çerçioğlu Özdemir and Süleyman Çağan Efe and Pınar Şen and Hatice Özdamar and Derya Seyman and Ayşe Batırel and Utku Zeybey and Çisem Oktay and Pelin Geyik Pekin and Selin Özdemir and Adem Köse and Kemalettin Özden and Oğuz Karabay and Şafak Kaya Kavak and Ali Mert and Sena Kaçan and Tuncay Güzel and Selda Aydın and Uğur Kostakoğlu and Seyit Ali Büyüktuna and Mesut Gitmez and Esma Kepenek Kurt and Fatma Zühre Alparslan Tanyeri and Veysi Can and Lütfü Bekar and Mehmet Çelik and Nazan Tuna and Şükran Köse and Mehmet Birhan Yılmaz},
  journal = {Journal of clinical medicine},
  year = {2026},
  month = oct,
  doi = {10.3390/jcm15197760},
  url = {https://europepmc.org/article/PMC/PMC13666091},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Contemporary Clinical Spectrum and Factors Associated with Mortality in Infective Endocarditis: A Multicenter Cohort Study (COSMO-IE)
AU  - Mehmet Kış
AU  - Oktay Şenöz
AU  - Duygu İnan
AU  - Onur Akhan
AU  - Esra Canbolat Ünlü
AU  - Özlem Güler
AU  - Tuba Tatlı Kış
AU  - Şemsi Nur Karabela
AU  - Duygu Çerçioğlu Özdemir
AU  - Süleyman Çağan Efe
AU  - Pınar Şen
AU  - Hatice Özdamar
AU  - Derya Seyman
AU  - Ayşe Batırel
AU  - Utku Zeybey
AU  - Çisem Oktay
AU  - Pelin Geyik Pekin
AU  - Selin Özdemir
AU  - Adem Köse
AU  - Kemalettin Özden
AU  - Oğuz Karabay
AU  - Şafak Kaya Kavak
AU  - Ali Mert
AU  - Sena Kaçan
AU  - Tuncay Güzel
AU  - Selda Aydın
AU  - Uğur Kostakoğlu
AU  - Seyit Ali Büyüktuna
AU  - Mesut Gitmez
AU  - Esma Kepenek Kurt
AU  - Fatma Zühre Alparslan Tanyeri
AU  - Veysi Can
AU  - Lütfü Bekar
AU  - Mehmet Çelik
AU  - Nazan Tuna
AU  - Şükran Köse
AU  - Mehmet Birhan Yılmaz
PY  - 2026
DA  - 2026/10/01
JO  - Journal of clinical medicine
DO  - 10.3390/jcm15197760
UR  - https://europepmc.org/article/PMC/PMC13666091
AB  - Background: Despite continuous advancements in diagnostic imaging and targeted antimicrobial protocols for infective endocarditis (IE), global epidemiological data show that both disease burden and incidence continue to rise. This study aimed to evaluate real-world diagnostic and treatment approaches in accordance with the 2023 European Society of Cardiology (ESC) IE Guidelines and to identify independent predictors of mortality in a contemporary patient cohort. Methods: This multicenter, retrospective cohort study analyzed data from 470 consecutive adult patients diagnosed with IE across 27 academic reference centers between 1 September 2023 and 1 June 2025. Patients were managed and adjudicated according to the 2023 ESC diagnostic criteria. Demographic data, clinical characteristics, microbiological profiles, imaging findings, empirical antibiotic therapy patterns, and clinical outcomes were analyzed. Independent predictors of mortality were determined using multivariable Cox proportional hazards regression models. Results: The mean age of the overall study population was 58.08 ± 16.81 years, with a male predominance (60.6%, n = 285). Staphylococcus aureus was the most frequently isolated pathogen (27.9%), with a high proportion of methicillin resistance (38.9%). Hospital-acquired IE was identified in 41.1% of cases. Surgical treatment was performed in 40.6% (n = 191) of the cohort. The 28-day mortality rate was 11.9%, and the overall mortality during follow-up reached 26.4%. Multivariable Cox regression analysis identified hospital-acquired IE (HR = 2.247; 95% CI: 1.216–4.167; p = 0.010) and the presence of major clinical complications (HR = 4.207; 95% CI: 1.556–11.378; p = 0.005) as the strongest independent predictors of mortality. Conclusions: Contemporary infective endocarditis is a highly complex and fatal disease characterized by a prominent healthcare-associated burden and a predominant staphylococcal etiology. The occurrence of major clinical complications and hospital-acquired infections were the primary independent predictors of mortality.
SN  - 2077-0383
ER  -